|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2007-7-24
|
|
pubmed:abstractText |
Overexpression of receptor activator of nuclear factor-kappaB ligand (RANKL) is a prominent feature of vulnerable atherosclerotic lesions prone to rupture and was thought to contribute to the transition from a stable to an unstable plaque phenotype in both human and murine atherosclerosis because of its ability to promote matrix degradation, monocyte/macrophage chemotaxis, and vascular calcification.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
24
|
|
pubmed:volume |
116
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
385-91
|
|
pubmed:meshHeading |
pubmed-meshheading:17620507-Adult,
pubmed-meshheading:17620507-Aged,
pubmed-meshheading:17620507-Biological Markers,
pubmed-meshheading:17620507-Cardiovascular Diseases,
pubmed-meshheading:17620507-Cohort Studies,
pubmed-meshheading:17620507-Female,
pubmed-meshheading:17620507-Follow-Up Studies,
pubmed-meshheading:17620507-Humans,
pubmed-meshheading:17620507-Male,
pubmed-meshheading:17620507-Middle Aged,
pubmed-meshheading:17620507-Prospective Studies,
pubmed-meshheading:17620507-RANK Ligand,
pubmed-meshheading:17620507-Risk Factors,
pubmed-meshheading:17620507-Solubility
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Soluble receptor activator of nuclear factor-kappa B ligand and risk for cardiovascular disease.
|
|
pubmed:affiliation |
Department of Neurology, Innsbruck Medical University, Anichstr 35, A-6020 Innsbruck, Austria. Stefan.Kiechl@i-med.ac.at
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
